149 related articles for article (PubMed ID: 4849779)
1. [Studies in the benzofuran series. LV. Fibrinolytic properties of inicarone].
Barchewitz G; Brotelle R; Guilbert A; Charlier R
Therapie; 1974; 29(1):57-70 passim. PubMed ID: 4849779
[No Abstract] [Full Text] [Related]
2. [Studies on substances in the benzofuran group. 43. Angiotrophic, anti-inflammatory and fibrinolytic properties of benzarone].
Chaillet F; Barchewitz G; Charlier R; Guilbert A; Colot M; Deltour G
Arzneimittelforschung; 1970 Mar; 20(3):358-63. PubMed ID: 4392593
[No Abstract] [Full Text] [Related]
3. [Thrombolytic action of the enzymatic preparation terrilytin].
Grinberg GE; Mikhaĭlets GA
Probl Gematol Pereliv Krovi; 1972 Sep; 17(9):21-7. PubMed ID: 4668372
[No Abstract] [Full Text] [Related]
4. [Activation of euglobulin lysis induced by Atheroid (R)].
Prino G; Mantovani M; Butti A
Boll Soc Ital Biol Sper; 1969 Jan; 45(2):133-7. PubMed ID: 5346780
[No Abstract] [Full Text] [Related]
5. Mechanism of action of nafazatrom.
Seuter F; Busse WD
Thromb Res Suppl; 1983; 4():75-80. PubMed ID: 6415860
[No Abstract] [Full Text] [Related]
6. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
Herold R; Straub PW
J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
[No Abstract] [Full Text] [Related]
7. Effects of ellagic acid upon the human fibrinolytic system.
Iatridis SG; Iatridis PG; Ferguson JH
Thromb Diath Haemorrh; 1966 Dec; 16(3):656-67. PubMed ID: 4231538
[No Abstract] [Full Text] [Related]
8. [Controlled experimental study of the relations between fibrinolytic acitivity and anticoagulant activity in evaluation of activators of fibrinolysis].
Cascone A; Lampugnani P
Minerva Med; 1969 Dec; 60(99 Suppl):5039-45. PubMed ID: 4188588
[No Abstract] [Full Text] [Related]
9. [The antithrombotic and thrombolytic activity of tuftsin].
Liapina LA; Pastorova VE; Kondashevskaia MV; Kudriashov BA; Kalikhevich VN; Kamenskiĭ AA; Ashmarin IP
Biull Eksp Biol Med; 1993 Nov; 116(11):451-2. PubMed ID: 8312523
[No Abstract] [Full Text] [Related]
10. [New hypothesis on fibrinolysis and coagulation mechanisms. Application in several experimental facts].
Daver J; Desnoyers P
Anesth Analg (Paris); 1974; 31(4):539-49. PubMed ID: 4440895
[No Abstract] [Full Text] [Related]
11. [Use of the thromboelastograph for registration of the time of euglobulin lysis in normal rats and those with experimentally modified fibrinolysis].
Prino G; Mantovani M; Butti A
Farmaco Prat; 1969 Sep; 24(9):552-61. PubMed ID: 4187112
[No Abstract] [Full Text] [Related]
12. [To the mechanism of development of adrenaline induced hypercoagulation].
Kuznik BI; Mishchenko VP
Farmakol Toksikol; 1967; 30(4):463-7. PubMed ID: 5598903
[No Abstract] [Full Text] [Related]
13. [Effect of angiotensin II on the blood coagulation properties and fibrinolytic system of dogs in vitro].
Golubenkova NI; Ponomareva AG; Brin VB
Patol Fiziol Eksp Ter; 1980; (3):62-3. PubMed ID: 7402712
[No Abstract] [Full Text] [Related]
14. Effects on fibrin clot lysis of a trypsin inhibitor in peanuts (Arachis hypogaea).
Egeblad K
Thromb Diath Haemorrh; 1967 Feb; 17(1-2):31-41. PubMed ID: 5626247
[No Abstract] [Full Text] [Related]
15. [Current state of anticoagulant and fibrinolytic therapy].
Hladovec J
Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
[No Abstract] [Full Text] [Related]
16. [On thrombolysis with various fibrinolytic agents. II. In vitro studies on intravitally-formed human blood clots].
Schmidt HW
Klin Wochenschr; 1966 Jun; 44(11):621-5. PubMed ID: 5987967
[No Abstract] [Full Text] [Related]
17. Studies on the heterogeneity of fibrinolytic activity in artificially induced intravascular clots.
Ban I
Nagoya J Med Sci; 1967 Jun; 30(1):37-57. PubMed ID: 4229316
[No Abstract] [Full Text] [Related]
18. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
Cajozzo A; Citarrella P; Malleo C
Boll Soc Ital Cardiol; 1971; 16(3):117-26. PubMed ID: 4110180
[No Abstract] [Full Text] [Related]
19. [Effect of cytochrome C, sulnate and contrical on a change in the blood coagulating system and fibrinolysis during blood flow recovery in ischemic extremities].
Levandovskiĭ IV; Shal'nev AN
Patol Fiziol Eksp Ter; 1979; (6):26-9. PubMed ID: 94430
[No Abstract] [Full Text] [Related]
20. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
Hedlin AM; Monkhouse FC
Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
[No Abstract] [Full Text] [Related]
[Next] [New Search]
